Exploring vaccine to block maternal CMV transmission

A study out of Weill Cornell Medicine and Oregon Health & Science University provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus across the placenta to babies before they're born.

‘Flipping’ switch boosts stem cell numbers for therapies

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators. 

Join the climate action conversation: Center for Cities' spring symposium in New York City

On April 24, the Cornell Mui Ho Center for Cities will convene experts to share solutions and identify areas for future action that address the multiple and cascading climate change hazards facing New York City.

Around Cornell

Possible biomarker identified for Crohn’s disease with arthritis type

People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, according to a new study by Weill Cornell Medicine researchers.

$10.5M gift to Cornell will fund research using Empire AI

The gift from philanthropist Tom Secunda, co-founder of Bloomberg L.P., will help fund artificial intelligence-related research at Cornell Tech in New York City and at the Cornell Ann S. Bowers College of Computing and Information Science in Ithaca.

AI system can analyze serial medical images

A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, which may be useful across a wide range of medical and scientific applications.

How to Beat the Winter Blues and More: A Q&A With Cornell Tech’s New Therapist Sarah Rubenstein-Gillis

In the fall of 2024, Cornell Tech welcomed a counselor, Sarah Rubenstein-Gillis, dedicated to students on its campus in New York City.

Around Cornell

A 24-year partnership transforms health care in Tanzania

Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.

Islet-transplantation procedure shows promises against T1 diabetes

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.